APR Stock Overview
Apria, Inc. provides integrated home healthcare equipment and related services in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$37.26|
|52 Week High||US$40.00|
|52 Week Low||US$20.07|
|1 Month Change||21.49%|
|3 Month Change||6.15%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||59.50%|
Recent News & Updates
Calculating The Fair Value Of Apria, Inc. (NASDAQ:APR)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Apria, Inc...
|APR||US Healthcare||US Market|
Return vs Industry: Insufficient data to determine how APR performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how APR performed against the US Market.
|APR Average Weekly Movement||9.2%|
|Healthcare Industry Average Movement||8.0%|
|Market Average Movement||6.6%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: APR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: APR's weekly volatility (9%) has been stable over the past year.
About the Company
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients.
Apria Fundamentals Summary
|APR fundamental statistics|
Is APR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|APR income statement (TTM)|
|Cost of Revenue||US$236.77m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||2.03|
|Net Profit Margin||6.32%|
How did APR perform over the long term?See historical performance and comparison
Is Apria undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: APR ($37.26) is trading above our estimate of fair value ($13.25)
Significantly Below Fair Value: APR is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: APR is good value based on its PE Ratio (18.3x) compared to the US Healthcare industry average (20.5x).
PE vs Market: APR is poor value based on its PE Ratio (18.3x) compared to the US market (16.9x).
Price to Earnings Growth Ratio
PEG Ratio: APR is poor value based on its PEG Ratio (3.2x)
Price to Book Ratio
PB vs Industry: APR is overvalued based on its PB Ratio (57.2x) compared to the US Healthcare industry average (2.6x).
How is Apria forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APR's forecast earnings growth (5.6% per year) is above the savings rate (2%).
Earnings vs Market: APR's earnings (5.6% per year) are forecast to grow slower than the US market (13.1% per year).
High Growth Earnings: APR's earnings are forecast to grow, but not significantly.
Revenue vs Market: APR's revenue (4.7% per year) is forecast to grow slower than the US market (9.3% per year).
High Growth Revenue: APR's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: APR's Return on Equity is forecast to be very high in 3 years time (58.6%).
How has Apria performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: APR has a large one-off loss of $30.9M impacting its September 30 2021 financial results.
Growing Profit Margin: APR's current net profit margins (6.3%) are higher than last year (2.4%).
Past Earnings Growth Analysis
Earnings Trend: APR's earnings have declined by 5.2% per year over the past 5 years.
Accelerating Growth: APR's earnings growth over the past year (177.4%) exceeds its 5-year average (-5.2% per year).
Earnings vs Industry: APR earnings growth over the past year (177.4%) exceeded the Healthcare industry 32.5%.
Return on Equity
High ROE: Whilst APR's Return on Equity (319.04%) is outstanding, this metric is skewed due to their high level of debt.
How is Apria's financial position?
Financial Position Analysis
Short Term Liabilities: APR's short term assets ($324.1M) exceed its short term liabilities ($274.3M).
Long Term Liabilities: APR's short term assets ($324.1M) do not cover its long term liabilities ($431.7M).
Debt to Equity History and Analysis
Debt Level: APR's net debt to equity ratio (717.2%) is considered high.
Reducing Debt: Insufficient data to determine if APR's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: APR's debt is well covered by operating cash flow (48.8%).
Interest Coverage: APR's interest payments on its debt are well covered by EBIT (12.9x coverage).
What is Apria current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate APR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate APR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if APR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if APR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of APR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dan Starck (54 yo)
Mr. Daniel J. Starck, also known as Dan, has been Chief Executive Officer at Apria, Inc. since February 2015 and has been its Director December 2013. Mr. Starck served as the Chief Executive Officer of Apr...
CEO Compensation Analysis
Compensation vs Market: Dan's total compensation ($USD2.20M) is below average for companies of similar size in the US market ($USD3.72M).
Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.
Experienced Management: APR's management team is seasoned and experienced (8.8 years average tenure).
Experienced Board: APR's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: APR only recently listed within the past 12 months.
Apria, Inc.'s employee growth, exchange listings and data sources
- Name: Apria, Inc.
- Ticker: APR
- Exchange: NasdaqGS
- Founded: 2018
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$1.324b
- Shares outstanding: 35.52m
- Website: https://www.apria.com
Number of Employees
- Apria, Inc.
- 7353 Company Drive
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/20 23:50|
|End of Day Share Price||2022/01/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.